000 01379nam a2200385Ia 4500
001 EBC282102
003 MiAaPQ
005 20240120130156.0
006 m o d |
007 cr cn|||||||||
008 060717s2006 mau sb 001 0 eng d
010 _z 2006049868
020 _z0123693934 (alk. paper)
035 _a(MiAaPQ)EBC282102
035 _a(Au-PeEL)EBL282102
035 _a(CaPaEBR)ebr10151447
035 _a(CaONFJC)MIL70760
035 _a(OCoLC)437175624
040 _aMiAaPQ
_cMiAaPQ
_dMiAaPQ
050 4 _aRM301.63
_b.T36 2006
082 0 4 _a615/.19
_222
245 0 0 _aTarget validation in drug discovery
_h[electronic resource] /
_cBrian W. Metcalf and Susan Dillon, editors.
260 _aBoston, MA :
_bAcademic Press,
_c2006.
300 _axii, 279 p.
504 _aIncludes bibliographical references and index.
533 _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 0 _aDrug development.
650 0 _aDrugs
_xTesting.
650 0 _aHigh throughput screening (Drug development)
655 4 _aElectronic books.
700 1 _aMetcalf, Brian W.
700 1 _aDillon, Susan,
_d1952-
710 2 _aProQuest (Firm)
856 4 0 _uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=282102
_zClick to View
999 _c27319
_d27319